BR112018074709A2 - composições cosmética compreendendo esclareolido - Google Patents

composições cosmética compreendendo esclareolido

Info

Publication number
BR112018074709A2
BR112018074709A2 BR112018074709-2A BR112018074709A BR112018074709A2 BR 112018074709 A2 BR112018074709 A2 BR 112018074709A2 BR 112018074709 A BR112018074709 A BR 112018074709A BR 112018074709 A2 BR112018074709 A2 BR 112018074709A2
Authority
BR
Brazil
Prior art keywords
clarified
cosmetic compositions
light radiation
induced
cosmetic
Prior art date
Application number
BR112018074709-2A
Other languages
English (en)
Other versions
BR112018074709B1 (pt
Inventor
LE MAIRE Marielle
Meyer Imke
Vielhaber Gabriele
Original Assignee
Symrise Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symrise Ag filed Critical Symrise Ag
Publication of BR112018074709A2 publication Critical patent/BR112018074709A2/pt
Publication of BR112018074709B1 publication Critical patent/BR112018074709B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

a presente invenção pertence aos campos de produtos farmacêuticos e cosméticos, e diz respeito, por um lado um medicamento para a inibição de e refere-se também sobre o cosmético, uso não terapêutico para o tratamento de hiperpigmentação, particularmente induzido por radiação da luz do sol, induzida preferencialmente por radiação de luz visível.
BR112018074709-2A 2016-05-30 2016-05-30 Medicamento compreendendo esclareolido, método não terapêutico para tratamento da hiperpigmentação induzida por luz visível na faixa de 400 nm a 700 nm, e uso cosmético não terapêutico de esclareolido BR112018074709B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2016/062172 WO2017215729A1 (en) 2016-05-30 2016-05-30 Cosmetic compositions comprising sclareolide

Publications (2)

Publication Number Publication Date
BR112018074709A2 true BR112018074709A2 (pt) 2019-03-19
BR112018074709B1 BR112018074709B1 (pt) 2022-01-18

Family

ID=56121042

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018074709-2A BR112018074709B1 (pt) 2016-05-30 2016-05-30 Medicamento compreendendo esclareolido, método não terapêutico para tratamento da hiperpigmentação induzida por luz visível na faixa de 400 nm a 700 nm, e uso cosmético não terapêutico de esclareolido

Country Status (8)

Country Link
US (1) US20190117547A1 (pt)
EP (1) EP3463275A1 (pt)
JP (1) JP7098537B2 (pt)
KR (1) KR102657242B1 (pt)
CN (1) CN109562046A (pt)
BR (1) BR112018074709B1 (pt)
CA (1) CA3026135A1 (pt)
WO (1) WO2017215729A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10828241B2 (en) * 2018-06-15 2020-11-10 Sytheon Limited Skin lightening compositions and methods
KR102490596B1 (ko) * 2020-12-17 2023-01-19 주식회사 데코페이브 콘크리트 제품 첨가용 액상 광촉매 조성물

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3060172A (en) 1959-04-29 1962-10-23 Reynolds Tobacco Co R Process for recovering sclareol from clary sage
JPS6391315A (ja) 1986-10-06 1988-04-22 Iwao Shimizu 発毛促進剤
US6150381A (en) 1998-06-09 2000-11-21 R.J. Reynolds Tobacco Company Methods of treating microbial infection and therapeutic formulations therefor
JP3839618B2 (ja) 1999-05-13 2006-11-01 株式会社ノエビア エラスターゼ阻害剤、及びこれを含有して成る老化防止用皮膚外用剤
CN1376049A (zh) 1999-08-24 2002-10-23 宝洁公司 通过局部施用含肟化合物的组合物增白角质组织的方法
EP1272154B1 (en) 2000-04-04 2004-09-22 Color Access, Inc. Composition for improving skin lipid barrier function
TWI290469B (en) * 2000-07-12 2007-12-01 Medical & Pharm Ind Tech & Dev Method for manufacturing product with component capable of efficiently preventing inflammation and platelets agglutination form ginger and medical composition with the efficient component
DE10048596A1 (de) * 2000-09-30 2002-04-25 Henkel Kgaa Entzündungshemmende Wirkstoffe
US20020142013A1 (en) 2001-01-31 2002-10-03 Maes Daniel H. Cholesterol sulfate and amino sugar compositions for enhancement of stratum corneum function
US6387416B1 (en) 2001-04-05 2002-05-14 Thomas Newmark Anti-Inflammatory herbal composition and method of use
JP4759182B2 (ja) 2001-08-03 2011-08-31 花王株式会社 水溶性ショウキョウエキス
US20030072777A1 (en) 2001-10-05 2003-04-17 Maes Daniel H. Combinatorial anti-acne compositions
EP1446019B1 (en) 2001-11-23 2007-03-14 Unilever N.V. Water continuous food product with cooling flavour
US20030161802A1 (en) 2002-02-05 2003-08-28 Flammer Linda J. Anti-dandruff and anti-itch compositions containing sensate and sensate enhancer-containing compounds
JP2007008847A (ja) 2005-06-29 2007-01-18 Kao Corp 化粧料
CN1840162B (zh) 2006-01-23 2010-08-11 赵晓昂 复方栀姜豉总提取物及其制剂和用途
EP2014276A1 (en) 2007-06-20 2009-01-14 Cognis IP Management GmbH Cosmetic compositions comprising sclareolide and hesperidin methyl chalcone
JP2009073777A (ja) 2007-09-21 2009-04-09 Kao Corp 化粧料
WO2009087578A2 (en) 2008-01-08 2009-07-16 Foamix Ltd. Sensation modifying topical composition foam
KR101666372B1 (ko) 2010-05-25 2016-10-14 시므라이즈 아게 피부 및/또는 모발 라이트닝 활성제로서 멘틸 카바메이트 화합물
EP2593077B1 (en) 2010-05-25 2016-11-02 Symrise AG Cyclohexyl carbamate compounds as skin and/or hair lightening actives
IT1401141B1 (it) 2010-07-26 2013-07-12 Indena Spa Formulazioni contenenti estratti di echinacea angustifolia e di zingiber officinale utili nella riduzione dell'infiammazione e del dolore periferico
WO2012020070A2 (en) 2010-08-10 2012-02-16 Behrooz Kasraee Enhancement of the skin depigmentation
CN102451128A (zh) 2010-10-28 2012-05-16 曹晶晶 一种生姜洗发水
EP2695597B1 (en) * 2012-08-07 2019-07-24 Symrise AG Cosmetic compositions
ES2701758T3 (es) 2013-02-27 2019-02-25 Symrise Ag Extracto de jengibre para la protección de citoblastos
PL2774481T3 (pl) * 2013-03-08 2019-03-29 Symrise Ag Kompozycje przeciwdrobnoustrojowe
EP2789369B1 (en) * 2013-04-14 2018-06-06 Symrise AG A composition for lightening skin and hair

Also Published As

Publication number Publication date
EP3463275A1 (en) 2019-04-10
KR102657242B1 (ko) 2024-04-12
KR20190015344A (ko) 2019-02-13
WO2017215729A1 (en) 2017-12-21
CN109562046A (zh) 2019-04-02
US20190117547A1 (en) 2019-04-25
CA3026135A1 (en) 2017-12-21
JP7098537B2 (ja) 2022-07-11
JP2019517502A (ja) 2019-06-24
BR112018074709B1 (pt) 2022-01-18

Similar Documents

Publication Publication Date Title
BR112018076198A2 (pt) medicamento e composição cosmética compreendendo derivados do resorcinol
BR112015016018A2 (pt) composição para cuidado dos cabelos
CL2016002346A1 (es) Composiciones para modular la expresión de ataxina 2
CL2015001916A1 (es) Derivados de pirimidona y su uso en el tratamiento, mejora o prevención de una enfermedad viral.
CL2015002472A1 (es) Como inhibidores de mutant idh-yl-oxazolidin-2-onas 3-pirimidin-4.
BR112017002053A2 (pt) composto de acordo com a fórmula (i), composição farmacêutica, e usos de um composto
CL2014000956A1 (es) Compuestos derivados de (4-fenilimidazol-2-il)etilamina, como moduladores de canal de sodio; composicion farmaceutica que los comprende; y su uso en el tratamiento del dolor.
CL2014002258A1 (es) Anticuerpos dirigidos contra metaloproteinasas de matriz 9 (mmp9 gelatinasa b); composicion farmaceutica que lo contiene; y sus usos.
BR112019002646A2 (pt) composições de poxvírus quimérico e usos das mesmas
BR112015023760A2 (pt) compostos e composições terapêuticas
CR20120508A (es) PROTEÍNA DE FUSIÓN ROBO1-Fc Y SU UTILIZACIÓN EN EL TRATAMIENTO DE TUMORES
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
GT201600250A (es) Compuestos de 1, 3, 4- tiadiazol y uso de los mismos para el tratamiento del cáncer
TR201910866T4 (tr) Kanser tedavisi için birleşik preparasyonlar.
BR112017018838A2 (pt) peptídeo possuindo atividade de branqueamento da pele e o uso do mesmo
BR112014011481A2 (pt) hidrolisado de colágeno e seu uso
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
BR112018074709A2 (pt) composições cosmética compreendendo esclareolido
BR112018069018A2 (pt) medicamento
DK3354169T3 (da) Skønhedsspejl med farefri desinfektion
BR112016026470A2 (pt) Composto modulador de hsp70, composição farmacêutica que o compreende e uso do referido composto
MX2018002859A (es) Extracto de gardenia para colorear la piel.
BR112014030949A2 (pt) "composição, processo para o tratamento cosmético e uso de uma composição"
ES2514140B1 (es) Uso del inhibidor de sulfatasas esteroideas STX64 para el tratamiento del envejecimiento
BR112017004304A2 (pt) composições de pteroestilbeno tópicas para uso em tratamento de perda de função de barreira na pele induzidas por uv

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/05/2016, OBSERVADAS AS CONDICOES LEGAIS.